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 3 
Abstract 4 
 5 
Increasing pressure on healthcare demand and delivery has resulted in the development of 6 
new roles and services for pharmacists. As current models of pharmacy practice continue to 7 
be evaluated, pharmacists must be involved in identifying new areas that may require 8 
research. In order to do so, the current vision of the future of pharmacy practice is discussed 9 
in this commentary. Issues such as adequate funding, professional competency and building 10 
strong interprofessional relationships are still identified as major barriers to change. These 11 
barriers have been grouped into the themes that form a conceptual model of the factors 12 
affecting the future of pharmacy practice, which have led to the development of key 13 
questions for the future. 14 
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Introduction 21 
 22 
Changing population demographics have resulted in an increasing pressure on healthcare 23 
demand and delivery worldwide. These changes have led to challenges in the management 24 
of people, especially those living with long term conditions. In order to adapt to these 25 
challenges, there have been changes in the healthcare workforce, resulting in the 26 
development of new roles and services for pharmacists. 1  27 
 28 
It is said that effective medicines management and the expanding roles of pharmacists need 29 
to be coupled with organized technology infrastructure, along with support from 30 
professional training and ethical, legal and regulatory frameworks. 2,3 Evidence-based 31 
policymaking determines the funding priorities within the healthcare system. In order to 32 
firmly establish the necessity of the pharmacy profession, it is vital to show evidence 33 
through research that the adapting roles of pharmacists add value to the healthcare 34 
system.2 At present, pharmacy practice models are and will be continuously evaluated. For 35 
these evaluations to influence changes in policy, it is pertinent that practicing pharmacists 36 
actively participate in research to evaluate the relevancy of the services they deliver and to 37 
help identify new areas that may require research.2  These new areas for example, could be 38 
novel mechanisms by which pharmacists could deliver patient care. However, in order to 39 
make these projections, the current vision for the future of pharmacy must first be 40 
discussed. Therefore, the aim of this commentary is to discuss the future of pharmacy and 41 
present a conceptual model leading to questions. Answering these questions could help in 42 
solving the puzzle of how the pharmacy profession operates in a broader public policy 43 
context and its future role in improving healthcare efficiency. 44 
 45 
Future of pharmacy: current vision 46 
 47 
In response to budget cuts and an increase in demand for medical attention in the 48 
population, evidence from the literature suggests that the pharmacy profession provides an 49 
accessible and supportive environment to consumers.4,5 As a result, pharmacy practice is 50 
moving away from a dispensing-based to a more service-based model for healthcare 51 
delivery. Increased collaboration between healthcare professionals in primary and 52 
secondary care is enhancing patient-centered care by redistributing the workload so it is 53 
more tailored to patients’ needs.2,6  54 
 55 
Given that healthcare provision is no longer predictable or immune from disruptive change, 56 
there are many factors that significantly increase the scope for the future.7 However, issues 57 
such as adequate funding, remuneration and time constraints are still bigger barriers that 58 
are difficult to change.8 In addition, this has led to some pharmacists believing that 59 
pharmacists themselves are ultimate barriers to change in pharmacy practice9, whilst others 60 
believe that there needs to be a bigger emphasis on professional competency, enhanced 61 
leadership skills and a push towards organizational change.10,11 This shows that firstly, there 62 
is a need for there to be system-wide understanding of the scope of a pharmacist, followed 63 
by an overhaul in the support structure in place that can be used to define the role of the 64 
pharmacist within the healthcare system as a whole. Overall, studies on the future of 65 
pharmacy practice agree that the future of the pharmacist in practice is that of a service 66 
provider.2,6,12–14 However, in order to develop this future vision, there is a need for 67 
consistency in developing roles and strong interprofessional relationships between 68 
pharmacists, other healthcare professionals and key stakeholders. 69 
 70 
The need for sustainable growth of pharmacists’ roles and skills is key to the development 71 
of the pharmacy profession.  In this context, some studies have focused on workforce 72 
adaptation and mapping 10,11,15, whilst others have looked at service provision and 73 
evaluation. 5,8,14,16 This highlights the need for a clear and concise definition of what is 74 
meant by the term ‘future of pharmacy practice’. 75 
 76 
The need for a conceptual model 77 
 78 
Although there are multiple visions for the future of pharmacy practice, they lack clarity due 79 
to individual interpretations of the term ‘future of pharmacy practice’ A clear and concise 80 
definition could be achieved and enhanced by the development of a conceptual model, 81 
based upon that of Scahill et al. (2017), but with a greater focus on the future.17  82 
 83 
Other factors such as the use of technology and migration patterns of the population must 84 
be considered when mapping for the future.18 Conceptualizing these barriers in the form of 85 
a model which provide points for discussion and ultimately embracing these advances could 86 
bring about change in the future.  87 
 88 
The factors contributing to the future of pharmacy practice discussed can be viewed at in a 89 
narrow or broad manner, depending on the context in which they are required. Narrow 90 
concepts include those such as workforce patterns, funding, service provision and service 91 
evaluation. These concepts can be encompassed into broader themes that take these 92 
concepts into consideration when looking at the health system as a whole. This model is 93 
based on these broad themes, which have been categorized by the authors based upon 94 
their insights and experiences. In this particular model, the emphasis remains on pharmacy 95 
practice as the central point through which key themes relate. The themes that have been 96 
identified are; pharmacy as a key stakeholder in the healthcare system, pharmacy practice 97 
and the role of pharmaceuticals, pharmacy and public policy. 98 
 99 
 100 
 101 
Figure 1: A conceptual model of the factors influencing the future of pharmacy practice 102 
 103 
Pharmacy as a key stakeholder in the healthcare system 104 
 105 
Concerns about the sustainability of healthcare expenditures have fueled interest in the 106 
expanding roles of pharmacists in the healthcare system, a role which pharmacists are well-107 
suited to with their extensive training and expertise.13  Quality improvement objectives that 108 
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provide remuneration based on the quality of services provided show that the quality of 109 
pharmacy services are improving. This could go one step further, as in the case of the 110 
Netherlands, where there are quality indicators for all sectors of healthcare, bringing 111 
pharmacy onto the same level of discussion in healthcare decision-making.13 In addition, use 112 
of the Accountable Care Organization (ACO) model in the United States suggests that 113 
greater integration of pharmacy services in the management of safe, effective use of 114 
medicines could lead to overall costs to patients and insurers being reduced.19  115 
Not only are strong relationships between commissioners and local pharmaceutical 116 
committees important13, open dialogue with doctors, nurses and allied healthcare 117 
professionals are just as necessary to drive the future. Ultimately, shifting responsibilities 118 
and tasks from doctors to other healthcare professionals is dependent on the context in 119 
which they are implemented and on the reactions of all those involved in these changes.20 120 
Therefore, this relationship between pharmacy and other healthcare professionals needs to 121 
be defined before it can be developed further. 122 
 123 
Pharmacy practice, pharmaceuticals and economic efficiency 124 
 125 
There is a need to balance expenditure between spending on pharmaceuticals and 126 
remuneration for the delivery of pharmacy services. On one hand, managing drug 127 
expenditures and costs could reduce financial access and distribution barriers, such as 128 
through drug pricing transparency and generic substitution mechanisms, therefore causing 129 
less of a financial burden.20 On the other hand, reducing the number of pharmacy-led 130 
services provided could further increase the strain on healthcare demand and contribute to 131 
the growth of parallel private sectors, with a long-term increase in cost to the system.20 As a 132 
result, it is key to strike a balance between these factors, which could be achieved by clear 133 
mapping of concepts for the future. 134 
 135 
Pharmacy and public policy 136 
 137 
Public policy could influence the way pharmacy operates and integrates with overall 138 
healthcare. The impact it could have on broader public and health agenda includes 139 
medicines optimization, medicines management, acting as an information provider for 140 
consumers, pharmacists and public health campaigns. 21,22 According to Mossialos et al. 141 
(2015), policy documents highlight the increasing appetite for reconfiguring the 142 
responsibilities of the pharmacist profession. 13 Furthermore, pharmacists need to prove 143 
that their skills and expertise add value, which in turn can underpin changes in practice, 144 
funding and ultimately, policy.2  145 
 146 
In addition, pharmacy already plays a key part in the public health needs of the population. 147 
In community pharmacy for example, there is emphasis on campaigns such as antimicrobial 148 
resistance, smoking cessation and alcohol awareness.22,23 However, community pharmacists 149 
are the only health professionals who are not primarily rewarded for delivering healthcare 150 
and are consequently under-utilized as public health professionals.13 Also, according to 151 
Babar et al. (2018), some pharmacists would like to see research into practice models that 152 
do not make a profit out of delivering pharmacy services, whilst others are more interested 153 
in research relating to patient outcomes.2 Furthermore, in the study by Mossialos et al. 154 
(2015), the authors also propose devising new remuneration and performance-based 155 
incentive mechanisms.13 Therefore, exploring how these possibilities can relate to and 156 
ultimately improve the healthcare needs of the population from the perspective of the 157 
pharmacy profession are vital. 158 
 159 
Health policy, pharmaceutical policy and pricing policy 160 
Globally, drug pricing varies from being government-led and managed to being set by 161 
pharmaceutical companies themselves. Regardless of how they are set, current policy 162 
initiatives such as drug pricing transparency has led to decreased monopoly of the market, 163 
improving patient accessibility to medication therapy. 24 The importance of such 164 
transparency has been raised at the 72nd World Health Assembly, led by the World Health 165 
Organization, where member states have resolved to encourage public sharing of pricing 166 
and reimbursement information in order to ensure fair and affordable pricing around the 167 
world.25 Greater drug pricing transparency coupled with patient-centered, pharmacist-led 168 
services focused on medication therapy management could also play a role in lowering 169 
pharmaceutical spending. As a result, healthcare systems must respond to these changes in 170 
their models. This is to expand development into the future. 171 
 172 
 173 
Re-defining and remodeling complex environments: Questions for the future of pharmacy 174 
 175 
The themes discussed above have led to questions relating to future of pharmacy practice 176 
and for the further development of this concept. Re-defining and remodeling complex 177 
environments are not without their challenges. These challenges can be defined as from an 178 
individual, systemic and wider organizational point of view.  For example, in England, there 179 
are many visions and new models of practice for the future of pharmacy that have been 180 
developed, little has been done to bind these together into a coherent narrative for the 181 
future roles of pharmacists within the National Health Service (NHS).14 In order to overcome 182 
the challenges discussed in this article, multi-collaborative research teams that have 183 
knowledge of organizational behavior and political sciences are necessary.6 184 
 185 
Key questions to explore based on the above themes could include: 186 
 187 
 Other than the points mentioned above, what other contextual, intrinsic and 188 
extrinsic factors are needed to define the term ‘future of pharmacy practice’? 189 
 How can the future relationship between pharmacy, healthcare and public policy be 190 
mapped out? 191 
 Can a model for future pharmacy services to improve health-related outcomes be 192 
developed? 193 
 194 
Conclusion 195 
 196 
This article concludes that the pharmacy profession needs to invest in its future by 197 
answering key questions on the expanding relationship between pharmacy, 198 
pharmaceuticals and economic efficiency, healthcare and public policy. The answers to 199 
these questions can be found by overcoming current barriers to change, leading to the 200 
identification of further themes that can be used to develop a future model for pharmacy 201 
practice. This model could then be used to inform challenging policy-making decisions 202 
within healthcare environments in order to improve health-related outcomes.  203 
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